诺和诺德Novo Nordisk（NVO）2025年第一季度投资者活动PPT「NYSE」（英文版）（173页）.pdf

1、Novo Nordisk a focused healthcare companyInvestor presentationFirst three months of 2025RAFAEL VALVERDERAFAEL VALVERDERafael lives with obesityMexico2Novo NordiskInvestor presentation First three months of 2025AgendaProgress on Strategic Aspirations 2025FinancialsInnovation and therapeutic focusComm

2、ercial executionAgenda3Novo NordiskInvestor presentation First three months of 20253Novo Nordisks statutory Annual Report 2024,Form 20-F,any quarterly financial reports,investor presentations and written information released,shown,or oral statements made,to the public in the future by or on behalf o

3、f Novo Nordisk,may contain certain forward-looking statements relating to the operating,financial and sustainability performance and results of Novo Nordisk and/or the industry in which it operates.Forward-looking statements can be identified by the fact that they do not relate to historical or curr

4、ent facts and include guidance.Words such as believe,expect,may,will,plan,strategy,transition plan,prospect,foresee,estimate,project,anticipate,can,intend,target and other words and terms of similar meaning in connection with any discussion of future operating,financial or sustainability performance

5、 identify forward-looking statements.Examples of such forward-looking statements include,but are not limited to:Statements of targets,future guidance,(transition)plans,objectives or goals for future operations,including those related to operating,financial and sustainability matters,Novo Nordisks pr

6、oducts,product research,product development,product introductions and product approvals as well as cooperation in relation thereto;Statements containing projections of or targets for revenues,costs,income(or loss),earnings per share,capital expenditures,dividends,capital structure,net financials and